4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000899243-22-024435
Chief Executive Officer sold 36,762 shares at $0.70 ($25,733)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-06-27 | Sale | −36,762 | $0.70 | $25,733 | 3,918,857 | D |
| Open-market sales · 36,762 sh · avg $0.70 · $25,733 | |||||||
Loading xslF345X03/doc4.xml…